Cargando…
Oxytocin in Huntington’s disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia
Neurodegenerative disorders (NDDs) such as Huntington’s disease (HD) and the spectrum of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are characterized by progressive loss of selectively vulnerable populations of neurons. Although often associated with motor impairments, the...
Autores principales: | Bergh, Sofia, Cheong, Rachel Y., Petersén, Åsa, Gabery, Sanaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515306/ https://www.ncbi.nlm.nih.gov/pubmed/36187357 http://dx.doi.org/10.3389/fnmol.2022.984317 |
Ejemplares similares
-
The Role of Hypothalamic Pathology for Non-Motor Features of Huntington’s Disease
por: Cheong, Rachel Y., et al.
Publicado: (2019) -
The Role of VCP Mutations in the Spectrum of Amyotrophic Lateral Sclerosis—Frontotemporal Dementia
por: Scarian, Eveljn, et al.
Publicado: (2022) -
Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum
por: Tse, Nga Yan, et al.
Publicado: (2022) -
Mutation spectrum of chinese amyotrophic lateral sclerosis patients with frontotemporal dementia
por: Yang, Xunzhe, et al.
Publicado: (2022) -
CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia
por: Williams, Kelly L., et al.
Publicado: (2016)